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exposure promotes epigenetic transgenerational
inheritance of obesity
Michael K Skinner*, Mohan Manikkam, Rebecca Tracey, Carlos Guerrero-Bosagna, Muksitul Haque and Eric E NilssonAbstract
Background: Ancestral environmental exposures to a variety of environmental factors and toxicants have been
shown to promote the epigenetic transgenerational inheritance of adult onset disease. The present work examined
the potential transgenerational actions of the insecticide dichlorodiphenyltrichloroethane (DDT) on obesity and
associated disease.
Methods: Outbred gestating female rats were transiently exposed to a vehicle control or DDT and the F1
generation offspring bred to generate the F2 generation and F2 generation bred to generate the F3 generation.
The F1 and F3 generation control and DDT lineage rats were aged and various pathologies investigated. The F3
generation male sperm were collected to investigate methylation between the control and DDT lineage male
sperm.
Results: The F1 generation offspring (directly exposed as a fetus) derived from the F0 generation exposed
gestating female rats were not found to develop obesity. The F1 generation DDT lineage animals did develop
kidney disease, prostate disease, ovary disease and tumor development as adults. Interestingly, the F3 generation
(great grand-offspring) had over 50% of males and females develop obesity. Several transgenerational diseases
previously shown to be associated with metabolic syndrome and obesity were observed in the testis, ovary and
kidney. The transgenerational transmission of disease was through both female (egg) and male (sperm) germlines.
F3 generation sperm epimutations, differential DNA methylation regions (DMR), induced by DDT were identified.
A number of the genes associated with the DMR have previously been shown to be associated with obesity.
Conclusions: Observations indicate ancestral exposure to DDT can promote obesity and associated disease
transgenerationally. The etiology of disease such as obesity may be in part due to environmentally induced
epigenetic transgenerational inheritance.
Keywords: Environmental epigenetics, Metabolic syndrome, Obesity associated disease, Epimutations,
Disease etiology, Maternal transmissionBackground
A number of environmental factors such as toxicants
and nutrition have been shown to promote the epige-
netic transgenerational inheritance of adult onset disease
and phenotypic variation [1-3]. Examples of environ-
mental compounds include the fungicide vinclozolin
[4-6], plasticizers bisphenol-A (BPA) and phthalates [7],
dioxin [7-9], hydrocarbons [7,8], and pesticides [4,7,8].* Correspondence: skinner@wsu.edu
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2013Nutritional abnormalities such as caloric restriction and
high-fat diets can also promote transgenerational phe-
notypes [10]. Epigenetic transgenerational inheritance
involves the germline (sperm or egg) transgenerational
transmission of epigenetic marks that influence physio-
logical parameters and disease, in the absence of direct
environmental exposures [1,3]. This phenomenon has
been observed in plants [11], flies [12], worms [13], ro-
dents [4], and humans [14]. Therefore, your ancestors’
environmental exposures may influence your disease de-
velopment, even though you have never had a directLtd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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generational inheritance of disease appears to be a
factor in disease etiology that needs to be considered
and elucidated.
The present study was designed to examine the po-
tential transgenerational actions of the most common
historically used insecticide dichlorodiphenyltrichloro-
ethane (DDT) [15,16]. DDT has been banned from the
USA, but is used globally as an insecticide for control of
vectors for malaria and visceral leishmaniasis. DDT is 1
of the 12 chemicals proposed for elimination by the
2001 Stockholm Convention of United Nations Environ-
mental Program [17]. However, DDT use in Africa has
increased since the Stockholm Convention due to the re-
cent Gates Foundation Malaria Control Program [18].
The reported global use of DDT for disease vector con-
trol is 4,000 to 5,000 metric tons per year, with India be-
ing by far the largest consumer [19]. In 2006, the World
Health Organization issued a position statement pro-
moting the use of indoor residual spraying with DDT for
malaria vector control. Although DDT is a low-cost an-
timalarial tool, the possible adverse human health and
environmental effects of exposure must be carefully
weighed against the benefits to malaria control [16]. Re-
cent evidence indicates that indoor spraying causes high
levels of human exposure to DDT [20]. The direct
exposure toxic effects of DDT in humans have been
reviewed [15] and include reproductive disease [21],
neurological disease [22], developmental abnormalities
[23], and cancer [24]. Studies have also shown DDT’s
potential to cause birth defects in wildlife [25]. Exposure
to DDT and its breakdown product dichlorodiphenyldi-
chloroethylene (DDE) may be associated with adverse
health outcomes such as diabetes and obesity in chil-
dren [26,27].
The dramatic increase in obesity over the past 50 years
has suggested environmental factors are important in
the disease etiology. The prevalence of obesity has in-
creased substantially since the mid-20th century with an
accelerated rate of increase in the 1980s [28]. The US
Centers for Disease Control in 2010 reported that 33%
of adults in the US are obese and 17% of children be-
tween ages 2 to 19 are obese. Obesity has not only
increased in the US, but also increased in virtually every
country where detailed data are available [29]. The
primary causal factor suggested is overnutrition [28],
however, recent studies have suggested environmental
toxicants [28] such as plastics [30,31], hydrocarbons
[32], and tributyltin [33] can promote obesity in rodents.
Although overnutrition and reduced physical activity are
critical elements of the disease, other contributing fac-
tors include maternal age, endocrine disruptors, sleep
deprivation, pharmaceutical introgenesis, ambient tem-
perature, and intrauterine and intergenerational effects[28]. All these contributing factors have been shown to
be involved in obesity, but the underlying molecular
mechanisms are unclear. Genetic abnormalities have
been identified in a number of the genes associated with
obesity [34,35], however, no significant genome-wide as-
sociations have been shown to correlate with the ma-
jority of obese individuals [35]. In addition, no known
genetic mechanism could explain the rapid increase in
the incidence of obesity in the last 30 years. Clearly, gen-
etics will be a critical aspect of any disease, including
obesity, but it simply cannot explain many of the ele-
ments of the disease etiology. An alternate consideration
is the role of environmental epigenetics in obesity [28]
and in the developmental origins of disease [36]. The
present study further investigates the role of epigenetics
in the etiology of obesity.
Obesity is now known to be associated with a number
of different clinical conditions in a complex disease trait
known as metabolic syndrome [37]. Although a number
of diseases have associations, the functional link and cor-
relation remains to be elucidated. Predominant associated
conditions are insulin resistance [38] and polycystic ovar-
ian disease [39]. Other obesity-associated conditions in-
clude type 2 diabetes [40], non-alcoholic fatty liver disease
[41], obstructive sleep apnea [42], kidney/renal disease
[43] and testis disease and male infertility [44]. The scien-
tific literature suggests over 50% of females with polycystic
ovarian disease are obese [45,46]. Therefore, polycystic
ovarian disease and several other diseases that are associa-
ted with obesity are also investigated in the present study.
Although the direct exposure toxicity of DDT is docu-
mented [47], no previous transgenerational studies in-
volving DDT exposure have been reported. The present
study tests the hypothesis that DDT promotes the epi-
genetic transgenerational inheritance of obesity and as-
sociated disease. In the event DDT ancestral exposures
promote obesity in subsequent generations, in the ab-
sence of any direct exposures, the biohazards of DDT
are significantly greater than anticipated. It may be that
ancestral exposures to environmental toxicants such as
DDT have a significant role in the etiology of the obesity
observed in the current human population. Interestingly,
the F3 generation of the majority of the gestating women
exposed in the 1950s in the USA are adults today. The
elucidation of the epigenetic biomarkers and molecular
mechanisms involved in this environmentally induced
epigenetic transgenerational inheritance is anticipated to
lead to new diagnostics and therapeutics for obesity and
associated diseases.
Methods
Animal studies and breeding
Female and male rats of an outbred strain Hsd:Sprague
Dawley®™SD®™ Harlan (Indianapolis, IN) at about 70 and
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diet and ad lib tap water for drinking. To obtain time-
pregnant females, the female rats in proestrus were pair
mated with male rats. The sperm-positive (day 0) rats
were monitored for diestrus and body weight. On days 8
to 14 of gestation [48], the females were administered
daily intraperitoneal injections of DDT (either 50 or
25 mg/kg BW/day) or dimethyl sulfoxide (vehicle). The
p,p’-DDT was obtained from Sigma (St Louis, MO,
USA) (no. PS699) and was injected in a 20 μl dime-
thylsulfoxide (DMSO)/oil vehicle as previously described
[7]. Treatment lineages are designated ‘control’, ‘DDT’ or
‘lower’ dose DDT lineages. This is not meant to rep-
resent a ‘low’ dose analysis. The gestating female rats
treated were designated as the F0 generation. The off-
spring of the F0 generation rats were the F1 generation.
Non-littermate females and males aged 70 to 90 days
from F1 generation of control, DDT or low dose DDT
lineages were bred to obtain F2 generation offspring.
The F2 generation rats were bred to obtain F3 gener-
ation offspring. Outcross F4 generation offspring (n = 8
litters per lineage) were obtained by breeding the F3
generation males from control and low dose DDT line-
ages with wild type females. Reverse outcross F4 genera-
tion progeny (n = 8 litters per lineage) were obtained by
breeding the F3 generation females from control and
low dose DDT lineages with wild type males. The out-
cross and the reverse outcross individuals were main-
tained until 10 months of age and then euthanized for
tissue collection and disease evaluation. The F1 to F4
generation offspring were not themselves treated directly
with DDT. The control and DDT lineages were housed
in the same room and racks with lighting, food and
water as previously described [1,5,7]. All experimental
protocols for the procedures with rats were preapproved
by the Washington State University Animal Care and
Use Committee (IACUC approval no. 02568–029).
Tissue harvest and histology processing
Rats at 10 to 12 months of age were euthanized by CO2
inhalation for tissue harvest. Body and organ weights
were measured at dissection time. No significant chan-
ges in body weight were observed within this 2-month
period and statistical analysis did not identify this as a
confounder in the analysis. Testis, epididymis, prostate,
seminal vesicle, ovaries, uterus and kidney were fixed in
Bouin’s solution (Sigma) and 70% ethanol, then pro-
cessed for paraffin embedding by standard procedures
for histopathology examination. Tissue sections of 5 μm
were made and were either unstained and used for
terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) analysis or stained with
hematoxylin and eosin (H&E) stain and examined for
histopathology. Blood samples were collected at the timeof dissection, allowed to clot, centrifuged and serum
samples stored for steroid hormone assays.
Histopathology examination and disease classification
Obesity was assessed with an increase in body weight
and marked abdominal adiposity. The obesity classifi-
cation has been defined as these abnormalities and the
presence of associated pathologies [28,36,49-51]. Testis
histopathology criteria included the presence of a vacu-
ole, azoospermic atretic seminiferous tubule and ‘other’
abnormalities including sloughed spermatogenic cells in
center of the tubule and a lack of a tubule lumen. Testis
sections were examined by TUNEL assay (in situ cell
death detection kit, Fluorescein, Roche Diagnostics,
Mannheim, Germany). Prostate histopathology criteria
included the presence of vacuoles, atrophic epithelial
layer of ducts and hyperplasia of prostatic duct epithe-
lium as previously described [52,53]. No prostatic in-
traepithelial neoplasia (PIN) lesions were observed in
the prostates. Kidney histopathology criteria included re-
duced size of glomerulus, thickened Bowman’s capsule
and the presence of proteinaceous fluid-filled cysts. A
cut-off was established to declare a tissue ‘diseased’
based on the mean number of histopathological abnor-
malities plus 2 standard deviations from the mean of
control tissues by each of the three individual observers.
This number was used to classify rats into those with
and without testis, prostate or kidney disease in each
lineage. A rat tissue section was finally declared ‘dis-
eased’ only when at least two of the three observers
marked the same tissue section ‘diseased’. The propor-
tion of rats with obesity or tumor development was
obtained by accounting those that had these conditions
out of all the animals evaluated.
Ovary sections were stained with H&E stain and three
stained sections (150 μm apart) through the central por-
tion of the ovary with the largest cross section were eval-
uated. Ovary sections were assessed for two diseases,
primordial follicle loss and polycystic ovary disease.
Primordial follicle loss was determined by counting the
number of primordial follicles per ovary section and
averaging across three sections. An animal was scored as
having primordial follicle loss if the primordial follicle
number was less than that of the control mean minus 2
standard deviations. Primordial follicles had an oocyte
surrounded by a single layer of either squamous or both
squamous and cuboidal granulosa cells [8,54]. Follicles
had to be non-atretic and showing an oocyte nucleus in
order to be counted. Polycystic ovary was determined by
microscopically counting the number of small cystic
structures per section averaged across three sections. A
polycystic ovary was defined as having a number of
small cysts that was more than the control mean plus 2
standard deviations. Cysts were defined as fluid-filled
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blood cells and which were not follicular antra. A single
layer of cells may line cysts. Small cysts were 50 to
250 μm in diameter measured from the inner cellular
boundary across the longest axis. Percentages of fe-
males with primordial follicle loss or polycystic ovar-
ian disease were computed.
Overall disease incidence
A table of the incidence of individual diseases in rats
from each lineage was created and the proportion of in-
dividual disease, total disease and multiple disease inci-
dences was computed. For the individual diseases, only
those rats that showed a presence of disease (plus) or
absence of disease (minus) are included in the computa-
tion. For the total diseases, a column with total number
of diseases for each rat was created and the number of
plus signs were added up for each of the rats and the
proportion was computed as the number of rats with
total disease out of all the listed rats. For the multiple
diseases, the proportion was computed as the number of
rats with multiple diseases out of all the listed rats.
Epididymal sperm collection and DNA isolation and
methylated DNA immunoprecipitation
The epididymis was dissected free of connective tissue, a
small cut made to the cauda and placed in 5 ml of F12
culture medium containing 0.1% bovine serum albumin
for 10 minutes at 37°C and then kept at 4°C to im-
mobilize the sperm. The epididymal tissue was minced
and the released sperm centrifuged at 13,000 g and
stored in fresh nuclear isolation medium (NIM) buffer
at −20°C until processed further. Sperm heads were sep-
arated from tails through sonication following previously
described protocol (without protease inhibitors) [55] and
then purified using a series of washes and centrifuga-
tions [56] from a total of nine F3 generation rats per
lineage (control or DDT) that were 120 days of age.
DNA extraction on the purified sperm heads was per-
formed as described [57]. Equal concentrations of DNA
from three individual sperm samples were used to pro-
duce three DNA pools per lineage and employed for
chromatin immunoprecipitation of methylated DNA
fragments (MeDIP). MeDIP was performed as previously
described [7,57].
MeDIP-chip analysis
The comparative MeDIP-chip was performed with
Roche Nimblegen’s Rat DNA Methylation 3 × 720 K
CpG Island Plus RefSeq Promoter Array which contains
3 identical subarrays, with 720,000 probes per subarray,
scanning a total of 15,287 promoters (3,880 bp upstream
and 970 bp downstream from transcription start site).
Probe sizes range from 50 to 75 bp in length with themedian probe spacing of 100 bp. Three different com-
parative (MeDIP vs MeDIP) hybridization experiments
were performed (three subarrays) for DDT lineage ver-
sus control, with each subarray encompassing DNA
samples from six animals (three each from DDT and
control). MeDIP DNA samples from experimental line-
ages were labeled with Cy3 and MeDIP DNA samples
from the control lineage were labeled with Cy5. Selected
differential DNA methylation regions (DMR) identified
with the MeDIP-chip analysis were confirmed with a
MeDIP-quantitative polymerase chain reaction (QPCR)
analysis involving real-time PCR analysis of the MeDIP
samples as previously described [31,32].
Bioinformatic and statistical analyses of MeDIP-chip data
The bioinformatic analysis was performed as previously
described [7,57]. The statistical analysis was performed
in pairs of comparative immunoprecipitation hybridiza-
tions between DDT (D) and controls (C) (for example,
D1-C1 and D2-C2, D1-C1 and D3-C3, D2-C2 and
D3-C3). In order to assure the reproducibility of the
candidates obtained, only the candidates showing signifi-
cant changes in all of the single paired comparisons
(intersection) were chosen as a having a significant
change in DNA methylation between DDT lineage and
control lineage. This is a very stringent approach to se-
lect for changes, since it only considers repeated changes
in all paired analysis. The statistically significant dif-
ferential DNA methylated regions were identified and P
value associated with each region presented. Each region
of interest was then annotated for gene and CpG con-
tent. This list was further reduced to those regions with
an average intensity value exceeding 9.5 (log scale) and a
CpG density ≥1 CpG/100 bp.
Statistical analysis of rat organ and disease data
Individual animals from different litters were used for
analysis and n values presented for all experiments. For
statistical analysis, all the continuous data on body and
organ weights and apoptosis were used as input in the
program GraphPad Prism 5 statistical analysis program
and t tests were used to determine if the data from the
DDT lineages differ from those of control lineages. For
the number of rats with or without disease, logistic re-
gression analysis was used to analyze the data (control
or DDT and diseased or unaffected). A simple logistic
regression was performed using an online calculator tool
(http://vassarstats.net/logreg1.html). The binary outcome
variable was diseased/not diseased (for example, obese/
non-obese). The predictor variable was treatment (con-
trol vs DDT and control vs LD DDT) and each was per-
formed separately for the analysis. Each treatment group
was only compared to its own control using the num-
bers of affected/non-affected individuals evaluated for
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considered significant if the P value was less than 0.05.
Results
Transgenerational obesity and associated disease analysis
The transgenerational actions of control (vehicle DMSO),
DDT (50 mg/kg body weight) and a lower dose (LD) DDT
(25 mg/kg BW) administered female rats (F0 generation)
during days 8 to 14 of gestation were investigated.
The doses of DDT used are anticipated environmental
exposures [22,58]. The F1 (direct exposure) and F3
(transgenerational) generation rats of control, DDT
and lower dose DDT lineages were aged to 1 year and eu-
thanized for analysis. The testis, prostate, kidney, ovary
and uterus were collected and examined for histopatho-
logies. To assess if there was any direct fetal exposure to-
xicity to DDT the F1 generation litter size, sex ratio, body
weights and organ weights were measured (Additional
file 1: Table S1A). No effect was observed on litter size or
sex ratio (P >0.05). The body weights of the F1 generation
DDT and LD DDT were slightly reduced, while several
organ weights were slightly increased. Therefore, no overt
toxicity to DDT was observed in the direct in utero ex-
posed F1 generation lineages.Figure 1 Transgenerational obesity. Percentages of females (a) or males
dichlorodiphenyltrichloroethane (DDT) or lower dose (LD) DDT is indicated
above the respective bar graphs. A logistic regression analysis was perform
(*P <0.05; **P <0.01; ***P <0.001). The representative abdominal adiposity is
deposition indicated (arrows) around the liver, intestines, subcutaneous andThe incidence of obesity in DDT and LD DDT lineages
are presented in Figure 1a,b. The obesity was deter-
mined using an increase in body weight and abdominal
adiposity (fat deposition) and presence of associated dis-
ease. The body weights of the non-obese (506.6 ± 8.2 g,
male; 278.4 ± 2.7 g, female) compared to the obese
(515 ± 5.8 g, male; 297.1 ± 4.2 g, female) DDT and LD
DDT lineages indicated a statistically significant increase
in body weight in the DDT and LD DDT lineage obese
animals (P <0.05). Although the mean body weight for
all DDT and LD DDT lineage individuals was not in-
creased (Additional file 1: Table S1), all the obese
animals did have an increase in body weight. The magni-
tude of the statistically significant weight gain was not
large, but we did observe larger weight gain as the ani-
mals aged, as previously described [59]. No weight gain
effect was observed on younger 120-day-old animals,
indicating the obesity weight gain was an adult onset
condition. Analysis of the abdominal adiposity for a
non-obese (Figure 1c) compared to an obese (Figure 1d)
animal demonstrated a dramatic increase in abdominal
fat deposition (adiposity) on nearly all organs in obese
animals. An increased body weight and abdominal adi-
posity was observed in all the obese animals identified.(b) with obesity in the F1 and F3 generations. The
. The number of diseased rats/total number of rats (n value) is shown
ed and P values indicate a significant difference from controls
shown for non-obese (c) and obese (d) rats, with the pink fat tissue
epididymis in the obese animal.
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observed in the F1 generation DDT or LD DDT lineages
(Figure 1). In contrast, the F3 generation LD DDT
lineage females and males had 50% of the animals de-
velop obesity. In the F3 generation DDT lineage males
75% of the animals developed obesity. Although the
DDT and LD DDT F1 generation animals did not have
an altered incidence of obesity, the ancestral DDT and
LD DDT exposures were found to promote transge-
nerational (F3 generation) obesity in the majority of
males and females. Therefore, DDT was found to pro-
mote the transgenerational inheritance of obesity and as
discussed below the molecular mechanisms of F1 and F3
generation disease are distinct.
Since obesity is a component of a complex disease trait
(Figure 2), a number of the other obesity-associated dis-
eases (for example, testis disease, polycystic ovarian dis-
ease, and kidney disease) were investigated. The causal
correlation of these diseases remains to be determined,
but the presence of associated disease is presented. The
incidence of testis disease in DDT and LD DDT lineages
is presented in Figure 3a. Testis disease was charac-
terized by the presence of histopathology including
azoospermia, atretic seminiferous tubules, presence of
vacuoles in basal regions of seminiferous tubules,
sloughed germ cells in the lumen of seminiferous tu-
bules, and lack of seminiferous tubule lumen (Additional
file 2: Figure S1A). DDT exposure had no influence on
testis disease in the F1 generation males. Testis disease
incidence increased significantly in the F3 generation
DDT lineage with 47% of the males affected (Figure 3a).
Further analysis of the testis examined the number of
apoptotic spermatogenic cells in the testis and epidi-
dymal sperm counts (Figure 3b,c). Spermatogenic cell
apoptosis was decreased in the F1 generation DDT and
LD DDT lineages and increased in the F3 generation line-
ages compared to control. Sperm counts were decreased















Figure 2 Obesity and associated disease. The major diseases
previously shown to be associated with obesity are indicated with
those identified in the present study shown with a red box.was found to promote obesity-associated transgenera-
tional testis disease.
The incidence of ovarian disease in DDT and LD DDT
lineages is presented in Figure 3d. An increase in
ovarian disease was observed in both the F1 and F3 gen-
eration DDT lineages. The primary ovarian disease de-
tected was the development of polycystic ovaries with an
increase in the number of small and large cysts as previ-
ously described [60] (Figure 3e). In contrast to previous
environmental toxicants examined [60], no effect on
primordial follicle numbers were detected in the DDT
or LD DDT lineages (Figure 3f ). The increase in ovarian
disease in the F3 generation DDT and LD DDT lineages
observed was primarily characterized by the develop-
ment of ovarian cysts. Analysis of estradiol levels in the
proestrous or diestrous F3 generation females revealed
this was not changed in the DDT or LD DDT lineages
(Additional file 3: Figure S2C,D). Therefore, DDT and
LD DDT were found to promote the obesity-associated
transgenerational polycystic ovarian disease.
The incidence of kidney disease in DDT and LD DDT
lineages is presented in Figure 3g and 3h. Kidney di-
sease was characterized by the presence of an increased
number of proteinaceous fluid filled cysts, reduction in
size of glomeruli and thickening of Bowman’s capsules
(Additional file 2: Figure S1B). There was an increase in
female kidney disease in F1 and F3 generation LD DDT
lineage, but only in the F1 generation in the DDT lineage
(Figure 3g). The males showed a dramatic increase with
over 60% of the F1 and F3 generation animals in the LD
DDT lineage affected (Figure 3h). Therefore, DDT was
found to promote the obesity-associated transgenerational
kidney disease in both males and females.
Additional potential obesity-associated disease and ab-
normalities (Figure 2) investigated were prostate disease
[61], pubertal abnormalities [62], tumor development
[63] and immune abnormalities [64]. Prostate disease
was examined in the F1 and F3 generation males
(Additional file 2: Figure S1 and Table S2A). Prostate
disease was characterized by atrophic prostate duct epi-
thelium and hyperplasia (Additional file 2: Figure S1A)
as previously described [52]. The incidence of prostate
disease increased in F1 generation males of DDT and LD
DDT lineages, but no effect was observed in the F3
generation males. Therefore, no transgenerational pros-
tate disease was observed. In addition, no influence on
F3 generation male testosterone levels was observed
(Additional file 3: Figure S2E). Analysis of the onset of
puberty, as previously described [7], was found not to be
altered in either females (Additional file 3: Figure S2F)
or males (Additional file 3: Figure S2G) in the F1 or F3
generations. The incidence of tumor development was
monitored and the primary tumors observed were mam-










Figure 3 Transgenerational obesity and associated disease. Percentages of the F1 and F3 generation disease/abnormalities from control
(open bars), dichlorodiphenyltrichloroethane (DDT) (black bars) and lower dose (LD) DDT lineages. Testis disease (a), spermatogenic cell apoptosis
(b) and sperm counts (c), ovarian disease (d), polycystic ovarian disease (e) and primordial follicle pool loss (f) are presented. Percentages of
females (g) and males (h) with kidney diseases and percentages of females (I) and males (J) with incidence of multiple disease. The number of
diseased rats/total number of rats (n value) is shown above the respective bar graphs. Those showing numbers above the bars were analyzed
with a logistic regression analysis and those with a mean ± SEM indicated were analyzed with a t test with the P value indicated (*P <0.05;
**P <0.01; ***P <0.001) (Additional file 4: Table S2 and Additional file 5: Table S3).
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ation females (Additional file 3: Figure S2H). An increase
in tumor development was observed in the F1 gener-
ation DDT lineage males, but no effect was observed in
the F3 generation lineages (Additional file 3: Figure S2I).
Therefore, no transgenerational influence was observed
for prostate disease, pubertal abnormalities or tumor de-
velopment. Analysis of the uterus identified a significant
increase in uterine infection in the F3 generation DDT
lineage females, with over 70% of the animals affected
(Additional file 3: Figure S2B). Uterine infection was de-
termined by the enlargement of uterus, accumulation
of foul-smelling dark discolored purulent material and
presence of inflammation within the uterine horns.
Therefore, potential transgenerational immune abnor-
malities were detected in the females.
The incidence of multiple disease and abnormalities
(≥2) per rat was determined (Figure 3i,j). The incidence
of diseases in individual rats from control, DDT and LD
DDT lineages are presented in Additional file 4: Table S2
for F1 generation females (S2A) and males (S2B), and in
Additional file 5: Table S3 for F3 generation females (S3A)
and males (S3B). The incidence of multiple diseases in F1
generation females increased in the DDT lineage, while
the incidence in the F3 generation females increased in
approximately 50% of the animals in the DDT and LD
DDT lineages (Figure 3i). The incidence of multiple dis-
ease in the F1 generation males increased in the LD DDT
lineage, while the incidence in the F3 generation males in-
creased to affect approximately 60% of the animals in the
DDT and LD DDT lineages (Figure 3j). Therefore, expo-
sure of F0 generation females to two different doses of
DDT increased the incidence of obesity and associated
multiple diseases in the F1 and F3 generation male and fe-
male progeny.
Parental germline transmission of DDT-induced
transgenerational obesity and associated disease
An experiment was designed to determine if the epigen-
etic transgenerational inheritance of adult onset obesity
and associated disease is transmitted through the male
(sperm) and/or female (egg) germline. The F3 generation
control and LD DDT lineage animals were outcrossed to
wild-type animals to generate the F4 generation. The
outcross (OC) involved an F3 generation male being
crossed with a wild-type female and the reverse outcross
(ROC) involved an F3 generation female being crossed
with a wild-type male. The F4 generation animals were
aged to 10 months and then sacrificed to assess trans-
generational obesity and associated disease incidence as
previously described (Additional file 6: Tables S4 and
Additional file 7: Table S5).
The F3 generation LD DDT-induced transgenerational
obesity in the female was transmitted with a trend to theF4 generation outcross LD DDT lineage, but was not
statistically different (Figure 4a). In contrast, the F3 gen-
eration LD DDT-induced transgenerational obesity in
the male was transmitted to the F4 generation reverse
outcross LD DDT lineage (Figure 4b). Therefore, the
obesity in the female appears to be transmitted through
the male germline or require both parental germline
contributions, while the obesity in the male is transmit-
ted through the female germline. The LD DDT-induced
obesity-associated transgenerational testis disease was
transmitted to the F4 generation reverse outcross, LD
DDT lineage (P <0.06) (Figure 4c). Therefore, the testis
disease was transmitted through the female germline.
The LD DDT-induced obesity-associated transgene-
rational polycystic ovarian disease was transmitted to
the F4 generation reverse outcross LD DDT lineage
(Figure 4d). Therefore, the polycystic ovarian disease
was also transmitted through the female germline. The
LD DDT-induced obesity-associated transgenerational
kidney disease in the female was transmitted to the F4
generation reverse outcross LD DDT lineage with a
strong trend (P <0.09) (Figure 4e). The LD DDT-
induced transgenerational kidney disease in the male
was transmitted to both the F4 generation outcross and
reverse outcross LD DDT lineages (Figure 4f ). There-
fore, the female kidney disease was transmitted through
the female germline, but the male kidney disease was
transmitted by both the male and female germlines.
Combined observations indicate that the LD DDT-
induced transgenerational obesity and associated disease
is predominately transmitted through the female (egg)
germline, but specific diseases (for example, kidney) are
also transmitted through the male (sperm) germline.
This is one of the first observations that the female
germline can also transmit transgenerational disease.
Observations suggest the parental germline origins for
the transgenerational disease may be exposure specific
and also disease or organ specific.
Epigenetic transgenerational transmission of sperm
epimutations
The DDT-induced epigenetic transgenerational inhe-
ritance of obesity and associated disease requires the
germline transmission of epimutations [1-3]. Previously,
F3 generation sperm have been shown to have diffe-
rential DMR induced by vinclozolin [4,57] and a variety
of other environmental toxicants [7]. Interestingly, the
sperm epimutations induced appear to be unique to the
specific environmental exposure [7]. The present study
investigated the sperm epimutations induced by DDT
and present in the F3 generation sperm. Three different
experiments with each involving a different pool of three
different animals from different litters were used. The F3
generation control and LD DDT lineage sperm were
Figure 4 Transgenerational disease in F4 generation outcross or reverse outcross offspring for both male and female germline
transmission. Incidences of obesity in females (a) and in males (b), ovary disease (c), testis disease (d), kidney disease in females (e), in males (f),
of the F4 generation outcross (OC) (F3 dichlorodiphenyltrichloroethane (DDT) lineage male cross with wild-type female) or reverse outcross (ROC)
(F3 DDT lineage female cross with wild-type male) offspring of the control, DDT, and lower dose (LD) DDT F3 generation lineages. The number of
diseased rats/total number of rats (n value) in each lineage are shown above the bar. A logistic regression analysis with P value compared to
control is indicated (*P <0.05; **P <0.01; ***P <0.001).
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followed by a promoter tiling array chip (MeDIP-chip)
analysis as previously described [7,57]. Those DMR be-
tween the control and LD DDT lineage sperm samples
that were statistically significant (P <10-5) were identified
and termed epimutations. When the DMR were present
in all three different experiments they were termed
‘intersection’ DMR. A total of 39 intersection DMR were
identified and their chromosomal locations are indicated
in Figure 5a and Additional file 8: Table S6. As pre-
viously described [7], the majority (28 DMR) of the
intersection DMR were unique to the DDT exposure
(Figure 5b) and not common with those epimutationspreviously identified in vinclozolin, plastics, dioxin, pes-
ticide or hydrocarbon exposures [7,57] (Additional file 8:
Table S6). A less stringent analysis uses the mean aver-
ages of the three different experiments to identify signifi-
cantly different DMR termed ‘average’. Using a P <10-5
cut-off a total of 231 average DMR were identified as
shown in Figure 5a and Additional file 9: Table S7. Con-
firmation of the MeDIP-chip analysis DMR data used a
quantitative PCR MeDIP-QPCR analysis. Three genes
associated with the DMR from the intersection DMR list
were selected due to having high interconnectivity in the
gene network described below. The genes and statisti-
cally significant change (P <0.05) between control versus
Figure 5 Transgenerational F3 generation sperm epimutations. (a) Chromosomal locations for differential DNA methylated regions (DMR) in
sperm DNA from F3 generation dichlorodiphenyltrichloroethane (DDT) lineage rats compared to control lineage (arrowheads). The high
stringency intersection epimutations are identified as red arrows, which is a subset of the less stringent ‘average’ DMR indicated with open
arrows. The chromosomal size and number are listed (Additional file 8: Table S6 and Additional file: 9 Table S7). (b) A Venn diagram of DMR from
various F3 generation exposure lineages including: vinclozolin, plastics, pesticides, hydrocarbons and DDT. The total number of DMR per exposure
lineage in brackets is presented and unique and overlapping DMR identified. (c) The CpG/100 bp is presented and the corresponding number of
DMR associated. The density is presented as the number of CpG for 100 bp of the DMR.
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Tubb3 (tubulin beta 3) (>13.8 fold change), Carm1
(coactivator-associated arginine methyltransferase) (>50
fold change), and Slc4a4 (solute carrier family 4 sodium
bicarbonate cotransporter member 4) (>10 fold change)
(Additional file 10: Figure S3). A profile of the MeDIP-
chip data for these genes is presented and compared to
the MeDIP-QPCR data (Additional file 10: Figure S3).
Therefore, the MeDIP-QPCR confirmed the MeDIP-
chip analysis for these DDT-induced sperm DMR. Ob-
servations demonstrate DDT induced a unique set of
epimutations in the F3 generation sperm.
A previous study identified a unique genomic feature
associated with the environmentally induced sperm
DMR [7,57]. The genomic feature identified in all trans-
generational sperm DMR previously identified is a low-density CpG of less than 10 CpG/100 bp [7,57]. These
low-density regions are termed ‘CpG deserts’ that con-
tain clusters of CpG [7]. The DDT transgenerational
sperm DMR were found to contain less than 15 CpG/
100 bp, with 3 to 6 CpG/100 bp being the most predom-
inant density (Figure 5c). Therefore, the low-density
‘CpG desert’ genomic feature was a component of the
DDT F3 generation sperm DMR.
Further bioinformatic analysis of the genes associa-
ted with the DMR in Table S7 identified a network of
interconnected genes using a literature-based analysis
(see Methods). A number of highly connected genes
were identified that are involved in extracellular, signaling
and transcriptional activities (Figure 6a). The potential
role of this gene network or specific signaling pro-
cesses in the DDT promoted epigenetic transgenerational
Figure 6 Transgenerational F3 generation sperm epimutation-associated gene network. (a) The gene network associated with the
differential DNA methylation regions (epimutations) with cellular location indicated. The green labeled genes are those in the high stringency
intersection set of 38 differential DNA methylated region (DMR) associated genes. (b) The genes that have a known link to obesity and polycystic
ovarian disease that are associated with dichlorodiphenyltrichloroethane (DDT) induced sperm DMRgenes are presented.
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analysis of the DMR-associated genes was to correlate
specific genes known to be associated with obesity with
the sperm DMR. The known obesity-associated genes had
13 correlated DMR (Figure 6b). The known obesity-associated genes also had three genes having correlation
with genes known to be associated with polycystic ovarian
disease. Therefore, a number of previously identified
obesity-associated genes correlated with the epimutations
identified.
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The present study demonstrates that ancestral DDT
exposure during a critical window of germline develop-
ment can promote the epigenetic transgenerational in-
heritance of obesity and a number of associated complex
disease traits. The doses of DDT used have been shown
to be wildlife and human environmental exposure levels
[22,58]. The human DDT lowest observed adverse effect
level LOAEL is 0.25 mg/kg/day which is lower than that
used in the present study. The objective of the present
study was to determine the potential transgenerational
actions of DDT, such that a higher dose was used initially.
We administered through an intraperitoneal injection to
determine the potential to promote phenotypes. Previous
studies have shown intraperitoneal injection is less stress-
ful than oral gavage and less problematic to promote
indirect effects from mode of administration [65]. There-
fore, the present study was not designed as a risk assess-
ment analysis for DDT exposures, but to determine the
potential ability of DDT to promote transgenerational
phenotypes. Future research can now use the information
obtained to design risk assessment studies with more ap-
propriate modes of administration for environmental
doses. However, the observations do demonstrate the abi-
lity of ancestral DDT exposures to promote transgenera-
tional adult onset obesity and associated disease.
The most dramatic increase in the incidence of adult
onset disease observed was with obesity and was only in
the F3 generation. Over 50% of the males and females
with ancestral DDT exposure developed an obesity con-
dition of increased body weight and abdominal adiposity.
Previous reviews of the definition and cause for obesity
suggest that weight gain, adiposity and presence of other
obesity-associated disease is sufficient to refer to the
pathology observed as obesity [28,36,49-51]. The US
Centers for Disease Control in 2010 reported that 33%
of adults in the US are obese and 17% of children be-
tween ages 2 to 19 are obese. Obesity is a contributing
factor and/or precursor for many other diseases inclu-
ding polycystic ovarian disease, testis disease, kidney
disease, liver disease, cardiovascular disease, type 2
diabetes, and diminished average life expectancy [66]
(Figure 2). The dramatic increase in obesity over the past
50 years suggests that environmental factors are import-
ant in the disease etiology. The primary causal factor
suggested is overnutrition [28,67,68]. However, recent
studies have suggested environmental toxicants such as
plastics [31], jet fuel hydrocarbons [32], and tributyltin
[33] can promote transgenerational obesity in rodents.
Waterland and colleagues suggested that epigenetic
mechanisms are involved in transgenerational transmis-
sion of maternal obesity [10]. The present study demon-
strated the epigenetic transgenerational inheritance of
obesity in both males and females following an ancestralDDT exposure. The two obesity conditions of weight
gain and abdominal adiposity are sufficient to identify
obesity [28,49,50], however, future studies will need to
assess the effects on other obesity parameters such as
bone mineralization, body length and metabolic dis-
ease. Interestingly, several obesity-associated diseases
were identified in the present study including polycys-
tic ovarian disease, testis disease and kidney disease
[9,27,44,45,69-72]. The obesity observed in humans
and rodents have similar disease phenotypes and associa-
tions [28,36]. The functional correlation of these diseases
needs to be elucidated. Interestingly, the DDT-induced
obesity was only observed in the F3 generation and not the
F1 direct exposure generation. The molecular mechanisms
involved in the F1 generation and F3 generation are dis-
tinct [1]. The F1 generation pathology is due to direct ex-
posure of the somatic cells of the fetus and does not
involve the germline. The F3 generation pathology is due
to a transgenerational germline mediated mechanism [1].
The epigenetic transgenerational inheritance of obesity in
the F3 generation is distinct from the somatic exposure
mechanism of the F1 generation [1,2]. Therefore, some
germline mediated detrimental effects of DDT could be
hidden for several generations before they become appar-
ent. Observations suggest ancestral exposures to DDT may
be a component of the rising incidence of obesity observed
in the current human population. Since the primary hu-
man exposures to DDT in the US occurred in the 1950s,
three generations have developed with a progressively in-
creasing incidence of obesity in the population. Therefore,
future studies are required to assess the importance of
ancestral DDT exposures to the etiology of obesity.
The transgenerational obesity-associated diseases and
abnormalities (Figure 2) observed include testis disease,
polycystic ovarian disease, immune abnormalities and
kidney disease. Direct DDT exposure has been shown to
promote testis disease in rats (7.5 mg/kg/day for 36
weeks) [22], alligators [58], and fish [73]. Interestingly,
male offspring of women exposed to DDT during preg-
nancy had an increase in testis disease observed 30 years
following the exposure [74]. Polycystic ovarian disease is
now the most common reproductive disease in women
leading to infertility and endocrine abnormalities [75]. A
number of environmental compounds have the ability to
promote transgenerational ovarian disease in rats [60].
Kidney disease has been shown to be induced following
direct DDT exposure in rats (10 mg/kg/day for 27 days)
[22] and in humans [76]. A number of environmental
toxicants can promote transgenerational kidney disease
in rats [7]. All these diseases (that is, testis, ovary, and
kidney) have increased dramatically over the past de-
cades suggesting a potential environmental component.
The presence of these associated diseases in the present
study supports the conclusion that DDT exposure of a
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tance of obesity and associated complex disease traits.
The environmentally induced epigenetic transgene-
rational inheritance of disease requires the germline
transmission of epimutations to subsequent generations
[1-4]. The present study identified the DDT-induced
transgenerational epimutations in the sperm of the F3
generation males. A comparison of these differential
DMR with DMR induced by other environmental toxi-
cants [7] demonstrated a unique DDT DMR signature
that may be used to assess ancestral DDT exposure. The
DDT transgenerational DMR had a low-density CpG
‘CpG desert’ genomic feature, as previously described
with other exposures [7,57]. These low-density CpG de-
serts containing clusters of CpG are speculated to be a
regulatory genomic feature associated with the DDT
DMR. Further studies are needed to elucidate the func-
tional significance of this DMR genomic feature. The
presence of the F3 generation DMR demonstrates a
transgenerational transmission of an epigenetic altera-
tion in the germline. Future studies will need to compare
the F3 generation DMR with the F1 and F2 generations.
The present study demonstrates the epigenetic transmis-
sion and inheritance of sperm epimutations.
Analysis of the genes associated with the DDT sperm
DMR identified a number of genes previously shown to
be involved in obesity or the associated polycystic ovar-
ian disease (Figure 6). The role of the DMR identified in
the regulation of these correlated genes remains to be
elucidated, however, these genes have previously been
shown to be associated with obesity. Observations pro-
vide potential mechanistic links with the pathologies ob-
served. Previous studies have shown that over 50% of
females with polycystic ovarian disease are over weight
or obese [45,69,70]. Therefore, a strong link exists be-
tween obesity and ovarian disease [69]. Interestingly, the
transmission of many of the DDT-induced disease states
was found to be through the female germline. This is
the first female-germline-transmitted transgenerational
phenotype identified. The imprinted-like nature of the
transgenerational phenotype [2] suggests a parent-of-
origin allele specific transmission of disease, which has
been shown to be either paternal or maternal. This mo-
lecular mechanism needs to be elucidated in future stud-
ies, but the present study demonstrates sex specific
germline transmission of transgenerational phenotypes.
Future studies are now needed to assess the DMR in the
egg induced by DDT. Observations suggest a potential
exposure and disease specificity to the parental origins
of the transgenerational phenomena.
Conclusions
Over 50 years have passed since the publication of the
book Silent Spring by Rachel Carson that argued thehazards of DDT to wildlife and human health [77]. Since
the Gates Foundation and World Health Organization
(WHO) have now promoted the use of DDT in Africa
and other developing countries for malaria control, the
potential hazards of current day exposures now need to
be considered in light of the transgenerational actions of
DDT. Although the number of lives saved from malaria
is significant, the long-term health and economic effects
on survivors [78] and subsequent generations also need
to be considered. Since other options exist with less
toxic shorter half-life pesticides, a more careful risk/
benefit consideration of the use of DDT is now needed.
The degree that environmentally induced epigenetic
transgenerational inheritance is involved in human obe-
sity and disease etiology is not known. However, since
the majority of chronic diseases have increased dramati-
cally over the past decades, environmental exposures and
transgenerational epigenetics will likely be a component of
disease etiology to seriously consider in the future. A more
thorough and mechanistic understanding of the molecular
etiology of disease, including the role of environmental
epigenetics, is anticipated to provide insights into new
diagnostics and therapeutics for specific diseases.Additional files
: Table S1. (A) Body weight and organ weights in F1
and F3 generation female rats of control, dichlorodiphenyltrichloroethane
(DDT) and lower dose DDT lineages (mean ± standard error). (B) Body
weight (g) and organ weights (% of body weight) in F1 and F3 generation
male rats of control, DDT and lower dose DDT (mean ± standard error).
Asterisks (*, **, ***), if present, indicate statistically significant differences
using a t test between 3 means of control and DDT or low dose DDT
lineages (P <0.05, P <0.01 and P <0.001, respectively); ND = not determined.
: Figure S1. Histopathology of transgenerational
disease. (A) The testis and prostate histopathology. (B) The male and
female kidney histopathology. The F3 generation control lineage (A),
dichlorodiphenyltrichloroethane (DDT) lineage (B), and lower dose DDT
lineage (C) for each tissue presented. The bar is 100 μm and insets of
higher magnification show the various pathologies described.
: Figure S2. Transgenerational physiological and
disease incidence in the F1 and F3 generation. Prostate disease (A) and
uterine infection (B) are presented. Serum estradiol concentrations in
proestrus-estrus in F3 generation control, dichlorodiphenyltrichloroethane
(DDT) and lower dose DDT lineage females (C). Serum estradiol
concentrations in diestrus in F3 generation control, DDT and low dose
DDT lineage females (D). Serum testosterone concentrations in the F3
generation control, DDT and low dose DDT lineage males (E). Pubertal
abnormalities in female (F) and male (G) animals. Tumor development in
female (H) and male (I) animals from the F1 and F3 generation control,
DDT, and low DDT dose lineages. The number of disease rates/total
numbers of rats (n value) in each lineage are shown above the bars.
Those showing numbers above the bars were analyzed with logistic
regression analysis and those with a mean ± SEM indicated were
analyzed with a t test with the P value represented (*P <0.05; **P <0.01;
***P <0.001).
: Table S2. (A) Individual disease incidence in F1
generation female rats of control, dichlorodiphenyltrichloroethane (DDT)
and lower dose DDT lineages. (B) Individual disease incidence in F1
generation male rats of control, DDT and lower dose DDT lineages. ‘+’
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control group, those with a ‘D’ belong to the DDT group and those
with ‘LD’ belong to the lower dose DDT group. See Methods section
for disease assessment in rats. The number of animals per litter
(litter representation) mean ± SEM used for each specific disease/
abnormality assessment within the control, DDT or lower dose DDT
lineages were not found to be statistically different (P >0.05), so no
litter bias was detected.
: Table S3. (A) Individual disease incidence in F3
generation female rats of control, dichlorodiphenyltrichloroethane (DDT)
and lower dose DDT lineages. (B) Individual disease incidence in F3
generation male rats of control, DDT and lower dose DDT lineages. ‘+’
indicates the presence and ‘-’ indicates the absence of disease; a blank
cell indicates ‘not determined’. Animal IDs with a ‘C’ belong to the
control group, those with a ‘D’ belong to the DDT group and those with
‘LD’ belong to the lower dose DDT group. See Methods section for
disease assessment in rats. The number of animals per litter (litter
representation) mean ± SEM used for each specific disease/abnormality
assessment within the control, DDT or lower dose DDT lineages were not
found to be statistically different (P >0.05), so no litter bias was detected.
: Table S4. (A) Individual disease incidence in
F4 generation outcross female rats of control and lower dose
dichlorodiphenyltrichloroethane (DDT) lineages. (B) Individual disease
incidence in F4 generation outcross male rats of control and lower dose
DDT lineages. ‘+’ indicates the presence and ‘-’ indicates the absence of
disease; a blank cell indicates ‘not determined’. Animal IDs with a ‘C’
belong to the control group, those with a ‘LD’ belong to the lower dose
DDT group. See Methods section for disease assessment in rats. The
number of animals per litter (litter representation) mean ± SEM used for
each specific disease/abnormality assessment within the control or lower
dose DDT lineages were not found to be statistically different (P >0.05),
so no litter bias was detected.
: Table S5. (A) Individual disease incidence in F4
generation reverse outcross female rats of control and lower dose
dichlorodiphenyltrichloroethane (DDT) lineages. (B) Individual disease
incidence in F4 generation Reverse Outcross male rats of Control and
Lower Dose DDT lineages. ‘+’ indicates the presence and ‘-’ indicates the
absence of disease; a blank cell indicates ‘not determined’. Animal IDs
with a ‘C’ belong to the control group, those with a ‘LD’ belong to the
lower dose DDT group. See Methods section for disease assessment in
rats. The number of animals per litter (litter representation) mean ± SEM
used for each specific disease/abnormality assessment within the control
or lower dose DDT lineages were not found to be statistically different
(P >0.05), so no litter bias was detected.
: Table S6. Dichlorodiphenyltrichloroethane (DDT)
induced F3 generation sperm differential DNA methylation regions (DMR)
(intersection). Epimutations found in F3-generation sperm after exposure
of F0 generation gestating females to DDT, obtained by intersection of
the five results of three methylated DNA fragment immunoprecipitation
(MeDIP)-chip comparative hybridizations. The genes in bold were found
to be unique DMR associated only with DDT-induced DMR.
: Table S7. Dichlorodiphenyltrichloroethane (DDT)
induced F3 generation sperm differential DNA methylation regions (DMR)
(average). Average found in F3-generation rat sperm after exposure of F0
generation to DDT, obtained averaging the results of three comparative
hybridizations.
: Figure S3. Immunoprecipitation of methylated DNA
fragments-quantitative polymerase chain reaction (MeDIP-QPCR)
confirmation of selected differentially methylated DNA regions (DMR).
Confirmation of MeDIP-chip identified DMR with an MeDIP-QPCR analysis.
(A) The DMR-associated genes Tubb3, Carm1, and Slc4c4 were selected
and QPCR with a real-time PCR analysis on MeDIP samples from control
and DDT lineage sperm samples performed. The relative changes
(DDT/control) are presented with the asterisks (*) indicating statistical
differences P <0.05. The MeDIP-chip profiles for (B) Carm1 DMR, (C)
Slc4c4 DMR, and (D) Tubb3 DMR are presented with the bars indicating
individual oligonucleotides probes and chromosomal location. The top






Additional file 10hybridization and the bottom black bar represents the control lineage F3
generation sperm MeDIP sample hybridization. The region with an
asterisk (*) above the bar represents statistical (P <0.05) alterations with
an increase in DDT MeDIP sample hybridization versus control. The data
represent the mean of three different experiments and associated samples
and the MeDIP-chip profiles are a representative hybridization profile.
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